Dydrogesterone Vs Combined Oral Contraceptive Pills for Treatment of Functional Ovarian cysts
Not Applicable
- Conditions
- Health Condition 1: N830- Follicular cyst of ovary
- Registration Number
- CTRI/2023/04/051811
- Lead Sponsor
- Jnmc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Female participants at reproductive age of
(18-44) years
Ovarian cyst of diameter 3-10cm in size,
present on one side with a single locule
and content should be clear
BMI: participants with BMI (18.5-24.9) of
normal range and overweight category (25-
29.9) included
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The recession of cysts in time duration of 3 months <br/ ><br>Change in the menstrual pattern (frequency, regularity, duration and volume) <br/ ><br>Timepoint: The recession of cysts in time duration of 3 months <br/ ><br>Change in the menstrual pattern (frequency, regularity, duration and volume) <br/ ><br>
- Secondary Outcome Measures
Name Time Method Duration of treatment needed <br/ ><br>Side effects <br/ ><br>Nausea, <br/ ><br>Vomiting, <br/ ><br>Weight gain, <br/ ><br>Acne, <br/ ><br>Effect on liver function tests <br/ ><br>Serious complications like thromboembolism delayed menses after treatment, drug interactions <br/ ><br>Timepoint: 3 months